Jonathan W. Stocker

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

Kenneth I. Ataga, Abdullah Kutlar, Julie Kanter et al. · New England Journal of Medicine · 2016 · 876 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia

Kenneth I. Ataga, Wally R. Smith, Laura M. De Castro et al. · Blood · 2008 · 234 citations · Full text

Medicine, Hematology, Pharmacology +6

Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso‐occlusive crises in patients with sickle cell disease: a phase III randomized, placebo‐controlled, double‐blind study of the gardos channel blocker senicapoc (ICA‐17043)

Kenneth I. Ataga, Marvin Reid, Samir K. Ballas et al. · British Journal of Haematology · 2011 · 227 citations

Medicine, Hematology, Pharmacotherapy +15

ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice

Jonathan W. Stocker, Lucia De Franceschi, Grant A. McNaughton-Smith et al. · Blood · 2003 · 202 citations · Full text

Medicine, Pharmacology, Physiology +11

Maurotoxin: A Potent Inhibitor of Intermediate Conductance Ca2+-Activated Potassium Channels

Neil A. Castle, Damian London, Christopher Creech et al. · Molecular Pharmacology · 2003 · 91 citations

Life Sciences, Pharmacology, Physiology +17